Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bardou

Showing results (461-470 of 636) with videos related to

Pageof 64
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 7, 1999
Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometriumM Bardou, J Cortijo, C Loustalot, et al.
Bone Marrow Transplantation|June 1, 2002
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantationA C Braud, M P Mathoulin Portier, V J Bardou, et al.
Scientific Reports|October 2, 2021
In silico identification of variations in microRNAs with a potential impact on dairy traits using whole ruminant genome SNP datasetsCéline Bourdon, Mekki Boussaha, Philippe Bardou, et al.
Alcoholism, Clinical and Experimental Research|September 1, 1996
Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic caucasiansD Lucas, C Ménez, F Floch, et al.
International Journal of Cancer|October 21, 2003
Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancerChristophe Ginestier, Valérie-Jeanne Bardou, Cornel Popovici, et al.
BMC Pregnancy and Childbirth|June 19, 2007
Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?Marc Bardou, Céline Rouget, Michèle Breuiller-Fouché, et al.
Surgical Oncology|November 26, 2008
Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancerLaurent Poincloux, Xavier Durando, Jean François Seitz, et al.
The Journal of Experimental Medicine|February 28, 2024
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodesMathilde Ruggiu, Marion V Guérin, Béatrice Corre, et al.
Journal of Clinical Periodontology|June 7, 2017
Periodontal status and serum biomarker levels in HFE haemochromatosis patients. A case-series studyVincent Meuric, Fabrice Lainé, Emile Boyer, et al.
Plos Genetics|October 3, 2013
The highly prolific phenotype of Lacaune sheep is associated with an ectopic expression of the B4GALNT2 gene within the ovaryLaurence Drouilhet, Camille Mansanet, Julien Sarry, et al.
Pageof 64

Showing results (461-470 of 636) with videos related to

Sort By:
Pageof 64
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 7, 1999
Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometriumM Bardou, J Cortijo, C Loustalot, et al.
Bone Marrow Transplantation|June 1, 2002
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantationA C Braud, M P Mathoulin Portier, V J Bardou, et al.
Scientific Reports|October 2, 2021
In silico identification of variations in microRNAs with a potential impact on dairy traits using whole ruminant genome SNP datasetsCéline Bourdon, Mekki Boussaha, Philippe Bardou, et al.
Alcoholism, Clinical and Experimental Research|September 1, 1996
Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic caucasiansD Lucas, C Ménez, F Floch, et al.
International Journal of Cancer|October 21, 2003
Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancerChristophe Ginestier, Valérie-Jeanne Bardou, Cornel Popovici, et al.
BMC Pregnancy and Childbirth|June 19, 2007
Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?Marc Bardou, Céline Rouget, Michèle Breuiller-Fouché, et al.
Surgical Oncology|November 26, 2008
Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancerLaurent Poincloux, Xavier Durando, Jean François Seitz, et al.
The Journal of Experimental Medicine|February 28, 2024
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodesMathilde Ruggiu, Marion V Guérin, Béatrice Corre, et al.
Journal of Clinical Periodontology|June 7, 2017
Periodontal status and serum biomarker levels in HFE haemochromatosis patients. A case-series studyVincent Meuric, Fabrice Lainé, Emile Boyer, et al.
Plos Genetics|October 3, 2013
The highly prolific phenotype of Lacaune sheep is associated with an ectopic expression of the B4GALNT2 gene within the ovaryLaurence Drouilhet, Camille Mansanet, Julien Sarry, et al.
Pageof 64